Jecko V. Thachil
#123,027
Most Influential Person Now
Jecko V. Thachil's AcademicInfluence.com Rankings
Jecko V. Thachilphilosophy Degrees
Philosophy
#5630
World Rank
#8489
Historical Rank
Logic
#2866
World Rank
#3936
Historical Rank

Download Badge
Philosophy
Jecko V. Thachil's Degrees
- Masters Medicine University of Kerala
- Doctorate Internal Medicine University of Kerala
- PhD Haematology University of Manchester
Why Is Jecko V. Thachil Influential?
(Suggest an Edit or Addition)Jecko V. Thachil's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 (2020) (1544)
- Coagulation abnormalities and thrombosis in patients with COVID-19 (2020) (1109)
- Guidelines for the diagnosis and management of disseminated intravascular coagulation (2009) (752)
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 (2020) (498)
- The versatile heparin in COVID‐19 (2020) (374)
- Coagulopathy of Coronavirus Disease 2019 (2020) (370)
- The unique characteristics of COVID-19 coagulopathy (2020) (342)
- Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines (2013) (304)
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation (2019) (283)
- Coagulopathy in COVID‐19 (2020) (268)
- New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey (2017) (204)
- Effects of the COVID-19 pandemic on supply and use of blood for transfusion (2020) (169)
- Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. (2009) (144)
- Vitamin B12 deficiency - A 21st century perspective . (2015) (133)
- DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC. (2016) (121)
- Management of surgical patients receiving anticoagulation and antiplatelet agents (2008) (111)
- Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma‐shock (COT/ACOTS) (2013) (110)
- Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects (2016) (109)
- Human CRP Defends against the Toxicity of Circulating Histones (2013) (104)
- The effects of cancer and cancer therapy on male fertility. (1981) (104)
- Catheter-related thrombosis: A practical approach (2016) (100)
- British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding (2018) (98)
- Practical guidance for the management of adults with immune thrombocytopenia during the COVID‐19 pandemic (2020) (96)
- Management of coagulopathy associated with postpartum hemorrhage: guidance from the SSC of the ISTH (2016) (96)
- SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism? (2020) (94)
- Anticoagulation in chronic kidney disease patients—the practical aspects (2014) (94)
- Whole genome sequencing of a sporadic primary immunodeficiency cohort (2018) (92)
- Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. (2015) (91)
- A proposal for staging COVID‐19 coagulopathy (2020) (84)
- Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension (2017) (84)
- Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH (2018) (80)
- Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation (2020) (78)
- Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy—Either, Neither, or Both (2020) (76)
- Perioperative management of patients on new oral anticoagulants (2014) (76)
- Proposal of the Definition for COVID-19-Associated Coagulopathy (2021) (72)
- How do we approach thrombocytopenia in critically ill patients? (2017) (71)
- Anticoagulant therapy for sepsis‐associated disseminated intravascular coagulation: the view from Japan (2014) (71)
- What do monitoring platelet counts in COVID‐19 teach us? (2020) (66)
- Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential (2019) (65)
- Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia (2017) (62)
- Towards standardization of clot waveform analysis and recommendations for its clinical applications (2013) (59)
- The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation] (2012) (56)
- How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults (2018) (55)
- Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH (2019) (55)
- Supportive management strategies for disseminated intravascular coagulation (2015) (54)
- ISTH DIC subcommittee communication on anticoagulation in COVID‐19 (2020) (52)
- Platelets in Inflammatory Disorders: A Pathophysiological and Clinical Perspective (2015) (51)
- Harmonisation of D-dimer - A call for action. (2016) (50)
- Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan (2016) (50)
- COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health (2020) (48)
- Venous thromboembolism in multiple myeloma – choice of prophylaxis, role of direct oral anticoagulants and special considerations (2018) (48)
- Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients (2020) (47)
- Management of cancer‐associated disseminated intravascular coagulation: guidance from the SSC of the ISTH (2015) (46)
- Relevance of clotting tests in liver disease (2008) (46)
- Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity (2016) (45)
- Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality (2020) (45)
- ISTH guidelines for antithrombotic treatment in COVID‐19 (2022) (45)
- D-Dimer Testing: Laboratory Aspects and Current Issues. (2017) (44)
- Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes (2018) (43)
- The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease (2021) (43)
- A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor. (2016) (41)
- The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. (2019) (41)
- A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH (2018) (41)
- Understanding the COVID‐19 coagulopathy spectrum (2020) (40)
- Exocrine function of testis with germinal testicular tumour. (1983) (39)
- Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH (2020) (39)
- Potential diagnostic markers for disseminated intravascular coagulation of sepsis. (2016) (38)
- Preservation techniques for human semen. (1981) (37)
- Appropriate use of D-dimer in hospital patients. (2010) (35)
- All those D‐dimers in COVID‐19 (2020) (35)
- Cerebral venous thrombosis-a primer for the haematologist. (2015) (35)
- Disseminated intravascular coagulation – new pathophysiological concepts and impact on management (2016) (35)
- Granulocytic sarcoma - a rare presentation of a breast lump. (2007) (34)
- The use of direct oral anticoagulants in chronic kidney disease (2018) (34)
- The need for accurate D‐dimer reporting in COVID‐19: Communication from the ISTH SSC on fibrinolysis (2020) (32)
- Iron deficiency without anaemia: a diagnosis that matters. (2021) (32)
- A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC (2018) (32)
- Hypoxia—An overlooked trigger for thrombosis in COVID‐19 and other critically ill patients (2020) (31)
- The clinical and functional relevance of microparticles induced by activated protein C treatment in sepsis (2011) (31)
- SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients (2021) (30)
- LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia (2016) (29)
- Antiplatelet therapy - a summary for the general physicians. (2016) (29)
- Rituximab‐induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia (2006) (28)
- De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures (2018) (26)
- Type and dose of heparin in Covid‐19: Reply (2020) (26)
- The use of fondaparinux in pregnancy (2015) (24)
- Disseminated intravascular coagulation in paediatrics (2016) (24)
- The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation. (2015) (24)
- Comparison of disseminated intravascular coagulation in trauma with coagulopathy of trauma/acute coagulopathy of trauma‐shock (2012) (24)
- Reintroduction of anti‐thrombotic therapy after a gastrointestinal haemorrhage: if and when? (2017) (24)
- Thromboembolic events are not uncommon in patients with immune thrombocytopenia (2010) (24)
- Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis (2020) (23)
- The Elusive Diagnosis of Disseminated Intravascular Coagulation: Does a Diagnosis of DIC Exist Anymore? (2019) (23)
- Management of disseminated intravascular coagulation: a survey of the International Society on Thrombosis and Haemostasis. (2015) (23)
- Current concepts in the management of disseminated intravascular coagulation. (2012) (22)
- Disseminated Intravascular Coagulation: A Practical Approach (2016) (22)
- The protective rather than prothrombotic fibrinogen in COVID‐19 and other inflammatory states (2020) (21)
- The newer direct oral anticoagulants: a practical guide. (2014) (21)
- The development of sarcoidosis with the use of alemtuzumab – clues to T‐cell immune reconstitution (2007) (21)
- Management of cancer‐associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply (2015) (20)
- A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia (2018) (20)
- Haematological Diseases in the Tropics (2013) (20)
- DIC in obstetrics: Diagnostic score, highlights in management, and international registry‐communication from the DIC and Women's Health SSCs of the International Society of Thrombosis and Haemostasis (2019) (20)
- Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation (2019) (20)
- Laboratory haemostasis monitoring in COVID‐19 (2020) (20)
- Anemia--the overlooked factor in bleeding related to liver disease. (2011) (19)
- Lessons from acute pancreatitis-induced thrombotic thrombocytopenic purpura. (2009) (18)
- The prothrombotic potential of platelet factor 4. (2010) (18)
- Thrombosis in immune thrombocytopenia — current status and future perspectives (2021) (17)
- Time for a hospital antacid policy on Clostridium difficile (2008) (17)
- Transfusion-Related Acute Lung Injury — A Review (2009) (16)
- Management of parturients with Factor XI deficiency-10year case series and review of literature. (2017) (16)
- SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP (2022) (16)
- Deep vein thrombosis (2014) (16)
- Thromboelastometry in critically ill patients with disseminated intravascular coagulation. (2019) (16)
- The current status of viscoelastic testing in septic coagulopathy. (2019) (16)
- Unsuspected pulmonary embolism (2010) (16)
- D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients (2020) (15)
- T‐regulatory cell response in psoriasis and changes with imatinib therapy (2009) (15)
- Is Rituximab‐induced Late‐onset Neutropenia a good prognostic indicator in lymphoproliferatve disorders? (2011) (15)
- Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation. (2016) (15)
- Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (14)
- Nitric oxide in transplantation-related thrombotic microangiopathy (2009) (14)
- Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: An immunologic link to a karyotypic abnormality (2008) (14)
- Nitric oxide in immune thrombocytopenic purpura (2009) (14)
- Recurrent venous thromboembolism while on anticoagulant therapy. (2012) (13)
- The problem of under-diagnosis and over-diagnosis of pulmonary embolism. (2019) (13)
- Sickle cell disease and COVID‐19: Atypical presentations and favorable outcomes (2020) (13)
- Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy (2021) (13)
- DOACs and “newer” hemophilia therapies in COVID‐19: Reply (2020) (13)
- Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel (2020) (13)
- Thrombotic thrombocytopenic purpura: is there more than ADAMTS‐13? (2007) (13)
- Early Host Interactions That Drive the Dysregulated Response in Sepsis (2019) (13)
- Nitric oxide and adverse events of vascular endothelial growth factor inhibitors (2011) (12)
- Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim (2013) (12)
- Clinical significance of measuring plasminogen activator inhibitor-1 in sepsis (2017) (12)
- Platelets and infections in the resource‐limited countries with a focus on malaria and viral haemorrhagic fevers (2017) (12)
- Addendum to the British Committee for Standards in Haematology (BCSH): Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11‐28) (2017) (12)
- “Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Reply (2021) (11)
- Non‐myeloablative transplantation for severe congenital neutropenia (2008) (11)
- Autoimmune haemolytic anaemia – an under‐recognized risk factor for venous thromboembolism (2008) (11)
- Management of bleeding and procedures in patients on antiplatelet therapy. (2020) (11)
- The problem of pulmonary embolism diagnosis in pregnancy (2015) (11)
- Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency (2017) (11)
- Physiological Levels of Pentraxin 3 and Albumin Attenuate Vascular Endothelial Cell Damage Induced by Histone H3 In Vitro (2016) (10)
- Modified ISTH pregnancy-specific DIC score in parturients with liver rupture: population-based case series (2019) (10)
- Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency (2017) (10)
- Is this immune thrombocytopenic purpura? (2007) (10)
- The enigma of pulmonary hypertension after splenectomy--does the megakaryocyte provide a clue? (2009) (10)
- Interstitial pneumonitis--An important differential diagnosis for pulmonary sepsis in haematology patients. (2012) (10)
- Addendum to the British Committee for Standards in Haematology (BCSH): guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant, 2004 (Br. J Haematol 2004,126,11‐28) ‐ response to Neisser‐Svae and Heger (2018) (10)
- A level‐headed approach to measuring direct oral anticoagulants: A 2‐year retrospective analysis of DOAC levels from a tertiary UK centre (2018) (10)
- Adverse effects of imatinib—Dissecting heart from the rest (2011) (10)
- Whole Blood for Civilian Urban Trauma Resuscitation: Historical, Present, and Future Considerations (2020) (9)
- Portal vein thrombosis – a primer for the general physician (2017) (9)
- The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis. (2009) (9)
- Emergency and out of hours care of patients with inherited bleeding disorders (2012) (9)
- Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal (2013) (9)
- Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's disease (2013) (9)
- Similarities and perspectives on the two C’s—Cancer and COVID‐19 (2021) (9)
- Thrombocytopenia with rituximab treatment—splenomegaly as the risk factor (2009) (9)
- Lessons learnt from COVID‐19 coagulopathy (2021) (9)
- Differentiating biochemical from clinical heparin resistance in COVID-19 (2020) (9)
- Does perfusion equal diuresis in the upper urinary tract? (1983) (8)
- Thrombotic thrombocytopenic purpura with the use of efalizumab for psoriasis (2008) (8)
- DOACs and ‘newer’ haemophilia therapies in COVID-19 (2020) (8)
- Inappropriateness of fresh frozen plasma for abnormal coagulation tests. (2012) (8)
- Clinical differentiation of anticoagulant and non‐anticoagulant properties of heparin (2020) (8)
- Is anticoagulating haemodialysis patients with non‐valvular atrial fibrillation too risky? (2018) (8)
- The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro (2017) (8)
- In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency (2016) (8)
- Hairy cell leukaemia, negative for conventional cell markers, diagnosed using antibodies to Annexin A1 and T‐bet (2010) (8)
- DIC in Pregnancy – Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments (2022) (8)
- Membranous glomerulonephritis--an under-reported histological finding in multiple myeloma. (2009) (7)
- Thrombocytopenia in the Intensive Care Unit (2014) (7)
- Multisystem failure due to three coexisting autoimmune diseases. (2009) (7)
- A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists (2018) (7)
- Re‐emergence of a low‐titre factor VIII inhibitor after liver transplant (2012) (7)
- Clinical implications of clotting screens (2015) (7)
- Screening Strategies for Hemochromatosis (2009) (7)
- Immature reticulocytes and its relevance to thrombosis (2008) (7)
- Iron deficiency: still under-diagnosed? (2015) (7)
- COVID-19 (SARS-CoV-2) in Non-Airborne body fluids: A systematic review & Meta-analysis. (2021) (7)
- The prevention of glucocorticoid‐induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper (2019) (7)
- Nitric oxide and the clinical manifestations of acute porphyria (2008) (7)
- Abnormal coagulation tests before kidney biopsies—what next? (2013) (6)
- Placental abruption as a trigger of DIC in women with HELLP syndrome: a population-based study (2020) (6)
- Nitric oxide depletion is responsible for the adverse effects of vascular endothelial growth factor inhibitors (2008) (6)
- Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion (2020) (6)
- Factor X deficiency presenting as a pseudotumor. Case report. (2006) (6)
- The myths about platelet transfusions in immune‐mediated thrombocytopenias (2010) (6)
- Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations. (2022) (6)
- Diagnosis of overt and non-overt disseminated intravascular coagulation: A survey among experts and a call for action from the ISTH. (2017) (5)
- Approach to the Diagnosis and Classification of Blood Cell Disorders (2016) (5)
- Alternate considerations for current concepts in ITP (2014) (5)
- Haematology in Critical Care: A Practical Handbook (2014) (5)
- Direct oral anticoagulants: a practical guide for the emergency physician (2016) (5)
- The application of anticoagulant therapy to sepsis (2017) (5)
- Evaluation of Google Glass™ with Camera Adaptor and GoPro™ as Teaching Tools for Endotracheal Intubation in the Austere Medical Environment (2018) (5)
- The difficult distinction between antiphospholipid syndrome and thrombotic thrombocytopenic purpura (2010) (5)
- Causes of thrombotic thrombocytopenic purpura. (2007) (5)
- Lessons from recurrent deep vein thrombosis in Glanzmann thrombasthenia (2013) (5)
- Reintroduction of anticoagulant therapy after intracranial haemorrhage: If and when? (2017) (5)
- A clue to the pathophysiology of posterior reversible encephalopathy syndrome. (2010) (5)
- Does COVID-19 Provide a Clue for Thrombosis in ITP? (2021) (5)
- Management of pregnancy in type 3 von Willebrand disease with alloantibodies (2018) (5)
- Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective? (2016) (5)
- Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia. (2012) (5)
- Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy (2021) (5)
- Lessons from a survey of genotyping for hereditary haemochromatosis (2015) (4)
- The malignant hypertension-thrombotic microangiopathy link. (2008) (4)
- Depression in adult patients with primary immune thrombocytopenia (2016) (4)
- Thrombotic Thrombocytopenic Purpura (2011) (4)
- A practical approach to thrombophilia testing. (2013) (4)
- Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers (2021) (4)
- The beneficial effect of acute phase increase in serum ferritin. (2016) (4)
- Example of the drug interaction between ciclosporin and orlistat, resulting in relapse of Evan's syndrome (2016) (4)
- Iron physiology, iron overload, and the porphyrias (2016) (4)
- Prothrombin complex concentrate to correct acquired abnormalities of the clotting screen in patients with liver impairment (2017) (4)
- D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. (2022) (4)
- Coagulopathy of sepsis from nonspecific inhibitors (2015) (4)
- A ploidy-agnostic method for estimating telomere length from whole genome sequencing data. (2018) (4)
- Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients (2020) (4)
- COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT) and the Shades of Grey in Thrombus Formation (2021) (4)
- The contribution of megakaryocytes to liver fibrosis (2009) (4)
- Iliofemoral deep vein thrombosis and the problem of post-thrombotic syndrome. (2018) (4)
- l-Asparaginase, nitric oxide and posterior reversible encephalopathy syndrome (2012) (4)
- How do you decide on hormone replacement therapy in women with risk of venous thromboembolism? (2017) (4)
- Managing sepsis‐associated coagulopathy remains an enigma (2019) (4)
- The role for adjunctive treatment to plasma exchange in thrombotic thrombocytopenic purpura. (2008) (4)
- Acquired haemophilia: an easy diagnosis to miss in a patient taking warfarin. (2015) (3)
- Practical Treatment Guidance for Cancer-Associated Thrombosis - Managing the Challenging Patient: A Consensus Statement. (2022) (3)
- Ligneous conjunctivitis with plasminogen deficiency (2009) (3)
- Steroids and arteriovenous thrombosis: the role of underlying disease. (2013) (3)
- A mystery unravels. (2007) (3)
- Problem-Based Review: Non Vitamin K Antagonist Oral Anticoagulants for the Acute Physician. (2015) (3)
- JAK2‐positive myeloproliferative neoplasm co‐existing with systemic mastocytosis (2011) (3)
- Management of a myocardial infarction in a patient with classical acquired haemophilia patient in partial remission (2015) (3)
- A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place (2020) (3)
- Iron metabolism, iron overload, and the porphyrias (2013) (3)
- Dilemmas in management of suspected venous thromboembolism in the obese patient. (2016) (3)
- Ventilation perfusion scan or computed tomography pulmonary angiography for the detection of pulmonary embolism? (2016) (3)
- Heparin-Induced Thrombocytopenia in the Intensive Care Unit (2010) (3)
- The authors reply. (2020) (3)
- Thrombocytopenia in an adult (2013) (3)
- Dispelling myths about coagulation abnormalities in internal medicine. (2014) (3)
- Fondaparinux as Alternative Anticoagulant to Warfarin or Low-Molecular-Weight Heparin for Recurrent Venous Thrombosis (2014) (3)
- Heparin induced thrombocytopenia with thrombosis: a two step process? (2008) (3)
- Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH (2022) (3)
- Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial (2020) (3)
- Haemophilia stress fractures – an increasing complication with better orthopaedic care (2013) (3)
- Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? (2021) (3)
- Mixing studies for abnormal coagulation screen – the current trend (2017) (3)
- You can bleed, you are on blood‐thinners! (2021) (3)
- Dilemmas in the use of new oral anticoagulants. (2015) (3)
- Erythropoietin corrects thrombocytopenia. (2013) (3)
- The possible role of reticulocytes in sickle cell disease associated thromboembolism (2008) (3)
- Surgical decision making around paediatric preoperative anaemia in low-income and middle-income countries. (2019) (2)
- Non‐factor therapies for bleeding disorders: A primer for the general haematologist (2022) (2)
- Reply to “Errors in the diagnosis for DIC due to a statistical misunderstanding” (2020) (2)
- Anticoagulation in thrombocytopenic patients – Time to rethink? (2022) (2)
- Do we need 'routine' blood counts? (2014) (2)
- The ups and downs of anticoagulation prescription in the United Kingdom (2019) (2)
- Two Factor XI Concentrates Correct Impaired Thrombin Generation in Major FXI Deficiency but Are Not Equivalent in Their Effect (2014) (2)
- When deep vein thrombosis occurs in the upper limb. (2016) (2)
- PFM.16 Third trimester amniocentesis for inherited bleeding disorders can be used to inform delivery management for at risk male fetuses (2014) (2)
- Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology (2021) (2)
- Exocrine Function of Testis with Germinal Testicular Tumour (1984) (2)
- The problem with incidental and chronic portal vein thrombosis. (2017) (2)
- Corrigendum to “Prognostic implications of leg ulcers from hydroxycarbamide therapy in patients with essential thrombocythaemia” [Leuk. Res. 36 (2012) 488–490] (2012) (2)
- Extreme thrombocytosis--an unusual presentation of inflammatory bowel disease. (2008) (2)
- Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (2)
- Congenital absence of inferior vena cava: an overlooked cause of deep vein thrombosis. (2016) (2)
- Anti-Xa based dose changes during low molecular weight heparin anticoagulation for mechanical prosthetic heart valves during pregnancy (2018) (2)
- Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia. (2007) (2)
- Why do thrombocytopenic patients bleed? (2013) (2)
- Haemolysis secondary to intravenous immunoglobulins for ITP (2013) (2)
- Faculty Opinions recommendation of Cardiovascular events and intensity of treatment in polycythemia vera. (2013) (2)
- Can direct oral anticoagulants be used in kidney transplant recipients? (2021) (2)
- Usefulness of Combining D-Dimers with Thromboelastography (2020) (2)
- Is coagulopathy a contraindication for thromboprophylaxis? (2013) (2)
- T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors--clues from and for sarcoidosis. (2009) (1)
- Who should request and interpret tests for heritable thrombophilia? (2007) (1)
- Practical management of the haemorrhagic complications of myeloproliferative neoplasms (2022) (1)
- Chronic deep vein thrombosis. (2018) (1)
- The relevance of the coagulation screen before surgery. (2017) (1)
- Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia (2021) (1)
- Are neutropenic patients at an increased risk of infection? (2012) (1)
- Handbook of Venous Thromboembolism (2017) (1)
- Investigating easy bruising in an adult (2017) (1)
- Successful Treatment of Disseminated Fusariosis With Ocular Involvement After Chemotherapy for Secondary Acute Myeloid Leukemia (2010) (1)
- Microangiopathic hemolytic anemia due to ADAMTS-13 loss in idiopathic systemic capillary leak syndrome. (2017) (1)
- Warfarin Management in Practice (2015) (1)
- A very elevated D-dimer level may potentially be useful. (2013) (1)
- Acquired Coagulation Disorders (2010) (1)
- The great imitator. Addison disease. (2010) (1)
- The disappearing spleen. (2010) (1)
- How long to anticoagulate? (2014) (1)
- Myelofibrosis in ITP and with TPO-RA – time to rethink? (2020) (1)
- Behcet's disease and refractory thrombosis. (2015) (1)
- Contact Activation Inhibition and Platelet Rich Plasma Are Required in Order to Differentiate Bleeders from Non-Bleeders in FXI Deficiency Using the Thrombin Generation Assay (2014) (1)
- [Urinary continence after radical prostatectomy: the urodynamic proof of an anatomical hypothesis (author's transl)]. (1976) (1)
- Potential Clues to the Pathogenesis of Acquired Hemophilia (2021) (1)
- Over-reliance of D-dimer in isolation to exclude venous thrombosis should be avoided. (2012) (1)
- Has deep vein thrombosis become a new epidemic? (2014) (1)
- Are white blood cells white? (2021) (1)
- Expecting the unexpected: Acquired haemophilia A in a patient with homozygous factor V deficiency (2019) (1)
- Nephrotic syndrome with spontaneous anticoagulant activity. (2006) (1)
- Dual origins and dual roles for von Willebrand factor (2021) (1)
- Similarities in coagulation for turophiles and clottologists (2021) (1)
- Management of venous thromboembolism in athletes. (2020) (1)
- Disseminated Intravascular Coagulation (2016) (1)
- UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey (2023) (1)
- Effect of diuresis and glucagon on upper urinary tract dynamics in the dog. (1985) (1)
- Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020) (1)
- Lipoproteins, statins and septic haematology patients (2011) (1)
- Plasma dabigatran activity one week after discontinuation despite normal renal function. (2013) (1)
- Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype. (2012) (1)
- Is it congenital or acquired von Willebrands disease? (2015) (1)
- Disease activity and venous thromboembolism in inflammatory bowel disease (2010) (1)
- Haematology in critical care (2015) (1)
- Thromboprophylaxis in COVID-19 – Rationale and considerations (2021) (1)
- Reduction of circulating histone toxicity is a major function of C-reactive protein after extensive tissue damage (2011) (1)
- British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding (Br J Haematol. 2018;181:54–67). Addendum August 2020 (2020) (1)
- Reactive oxygen species and mitogen-activated protein kinase activation in the development of Burkitt's lymphoma in Crohn disease. (2009) (1)
- Relevance of clotting screen requests. (2014) (1)
- Management of blood transfusion services in low‐resource countries (2022) (1)
- Why “the Love of Blood” in Hemophilia? (2021) (1)
- What is the evidence for platelet transfusion thresholds? (2014) (1)
- Long Term Eltrombopag in Paediatric Immune Thrombocytopenia: Update on UK Patients Treated with Eltrombopag As Part of the Petit and PETIT2 Studies (2017) (1)
- A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease (2022) (1)
- Can patients with pulmonary embolism be managed as an outpatient? (2016) (1)
- Dilemmas in the management of venous thromboembolism in older patients. (2017) (1)
- The misconceptions about warfarin. (2011) (1)
- Thrombocytopenia and thromboprophylaxis: a difficult combination? (2013) (0)
- Extreme warfarin hypersensitivity after oophorectomy. (2015) (0)
- Disseminated Intravascular Coagulation in Pregnancy: Insights in Pathophysiology, Diagnosis, and Management (2016) (0)
- The difficult distinction between haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura (2008) (0)
- Clopidogrel resistance in stroke patients (The CRISP Trial) (2014) (0)
- How to optimise anticoagulation for patients who are obese. (2020) (0)
- Working report on Clot Waveform Analysis Towards standardization and recommendations for clot waveform analysis (2012) (0)
- Monocyte Recruitment and Arthroplasty: Primary and Revision (2013) (0)
- Autoimmune haemolytic anaemia for the non-specialist. (2014) (0)
- Getting the anticoagulation right in the intensive care (2014) (0)
- Dilemmas in hematology: consults in patients with arterial thrombosis. (2023) (0)
- Thromboprophylaxis in Orthopaedics (2016) (0)
- Splenomegaly in the tropics (2014) (0)
- Reclassifying hemophilia to include definition of outcomes and phenotype as new targets. (2023) (0)
- Management of haemostatic complications of chimaeric antigen receptor T‐cell therapy (2022) (0)
- Providing accurate information to patients who develop deep vein thrombosis. (2013) (0)
- Thromboprophylaxis in gynaecology: a review of current evidence (2023) (0)
- Duration of anticoagulation: the decision-making process. (2015) (0)
- The authors reply (2020) (0)
- Faculty Opinions recommendation of VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice. (2014) (0)
- [Surgery of endocrine hyperfunctional state of suprarenal glands]. (1975) (0)
- Reduced elimination of Methotrexate in an adult with trisomy 21 and acute lymphoblastic leukaemia. (2007) (0)
- Why do patients with DIC bleed? (2021) (0)
- The platelet-skin connection (2022) (0)
- Spondylodiscitis from infection of central venous line inserted for haemophilia prophylaxis (2011) (0)
- What happens after prothrombin complex concentrate administration? (2013) (0)
- Ovarian malignancy revealed by anticoagulation. (2015) (0)
- Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasias on vascular endothelium-related biomarkers in disseminated intravascular coagulation. (2022) (0)
- Timing is crucial when considering antiplatelet therapy for trauma. (2013) (0)
- Clotting Screen Requests in Pediatrics (2012) (0)
- Faculty Opinions recommendation of Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. (2013) (0)
- Perioperative management of patients on new oral anticoagulants (2014) (0)
- Embolism—The journey from a calendar to the clot via the Lord’s prayer (2022) (0)
- Deciding on a combination of anticoagulant and antiplatelet drugs. (2015) (0)
- Hemostasis in tweeters (2021) (0)
- The underdiagnosis of pulmonary hypertension in myelofibrosis. (2010) (0)
- The patient with anaemia (2014) (0)
- To Bleed or Not to Bleed: Correcting Deranged Coagulation and Thrombocytopenia Prior to Transjugular Liver Biopsies: 489 (2013) (0)
- DIC score predicts mortality in massive clot coagulopathy as a result of extensive pulmonary embolism: a rebuttal (2010) (0)
- Faculty Opinions recommendation of Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. (2013) (0)
- Will direct oral anticoagulants completely replace warfarin? (2018) (0)
- Anemia as a potential contributor to bleeding in patients with liver disease - Neglected but not forgotten (2011) (0)
- Haemoglobinopathies and red cell enzymopathies (2014) (0)
- Blood coagulation and beyond: Position paper from the Fourth Maastricht Consensus Conference on Thrombosis. (2023) (0)
- The diagnosis of recurrent venous thrombosis--can a risk stratified approach at initial presentation be helpful? (2008) (0)
- Thrombosis with inflammatory bowel disease--bleed, clot or break. (2012) (0)
- New Insights on the Pathogenesis and Treatment of Crystal Arthritis (2013) (0)
- Faculty Opinions recommendation of P-selectin promotes neutrophil extracellular trap formation in mice. (2015) (0)
- Difficult transition from a new oral anticoagulant to parenteral anticoagulant in an overweight female (2015) (0)
- Iron deficiency: still under-diagnosed? Anaemia resulting from iron deficiency is one of the commonest diseases affecting humankind. Although its diagnosis and management may be straightforward, iron deficiency is underdiagnosed in nations with structured health-care systems, mainly because of a lac (2015) (0)
- Rotational thromboelastometry in critically ill COVID‐19 patients does not predict thrombosis (2022) (0)
- A survey of platelet aggregometry tests in a tertiary centre (2016) (0)
- Faculty Opinions recommendation of Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. (2012) (0)
- proplatelet formation causing thrombocytopenia Sphingolipid dysregulation due to lack of functional KDSR impairs Version 3 HAEMATOL / 2018 / 204784 (2019) (0)
- Is protein C zymogen really ineffective for ALL cases of sepsis including septic DIC? (2016) (0)
- Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. (2023) (0)
- Could bloodletting have helped? (2021) (0)
- Transferrin saturation in hemochromatosis: is there still a role? (2008) (0)
- A case of benign, multiple metastases. (2011) (0)
- The implications of aspirin resistance in renal failure (2008) (0)
- Reduced Intensity Conditioning Matched Unrelated Donor Allograft for Kostmann Syndrome. (2005) (0)
- Inpatient or Outpatient Anticoagulation (2017) (0)
- Primary radiotherapy for childhood ependymoma (2007) (0)
- Publisher Correction: Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data (2018) (0)
- Lessons from an incidental diagnosis of paroxysmal nocturnal haemoglobinuria (2012) (0)
- POS-472 THROMBOEMBOLISM IN PRIMARY NEPHROTIC SYNDROME (2022) (0)
- Challenges in managing patients on anticoagulation: Thrombocytopenia, resumption after bleeding and recurrent thrombosis (2022) (0)
- SP768RISK OF ALLOGRAFT THROMBOSIS AND USE OF THROMBOPHILIA SCREEN IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS (KTRS) -A SINGLE CENTRE EXPERIENCE (2017) (0)
- D-dimers: a most misunderstood test. (2021) (0)
- Recurrent thrombosis despite a therapeutic international normalised ratio. (2013) (0)
- Haematological diseases in the tropics. Chapter 65. (2013) (0)
- Re: half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup: S. F. Mishriki, R. Vint and B. K. Somani J Urol 2012;187:1561-1565. (2013) (0)
- Telomerecat: A ploidy-agnostic method for estimating telomere length from whole genome sequencing data (2018) (0)
- What should we do when a small pulmonary embolus is diagnosed unexpectedly? (2018) (0)
- Risk of venous thromboembolism in pregnancy and risks from unnecessary investigations must both be minimised (2013) (0)
- Platelet kinetics in patients with chronic immune thrombocytopaenia treated with thrombopoietin receptor agonists (2023) (0)
- Sub‐segmental and Incidental PE – to Treat or Not? (2017) (0)
- RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis‐induced coagulopathy than fibrin‐related markers: Response to the Letter‐to‐the‐Editor by Dr Wada (2020) (0)
- The problem with coagulopathy … (2022) (0)
- Osteoarthritis: Modification of the Inflammatory Response in Obese Patients by NSAIDs (2013) (0)
- History of the word “purpura” and its current relevance (2021) (0)
- Corrigendum: Portal vein thrombosis - a primer for the general physician. (2017) (0)
- Communication from the SSC of the ISTH on vascular endothelium-related biomarkers in DIC (2022) (0)
- Pre-eclampsia is an inflammatory disorder (2007) (0)
- Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study (2022) (0)
- Reticulocytes and erythroid precursors in haemolysis vasculopathy (2010) (0)
- D-Dimer and thrombosis in COVID-19 (2021) (0)
- The Abnormal Clotting Profile (2014) (0)
- Deep Vein Thrombosis is Common After Cardiac Ablation and Pre-Procedural D-Dimer Could Predict Risk. (2022) (0)
- Should low molecular weight heparin dosing be based on anti-Xa assays in antiphospholipid syndrome? (2013) (0)
- Microangiopathic hemolytic anemia due to ADAMTS‐13 loss in idiopathic systemic capillary leak syndrome: comment (2017) (0)
- Is NOAC without monitoring as good as warfarin? (2016) (0)
- The relation between fibrinogen level, neutrophil activity and nucleosomes in the onset of disseminated intravascular coagulation in the critically ill (2021) (0)
- Venous Thromboembolism in Intensive Care (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jecko V. Thachil?
Jecko V. Thachil is affiliated with the following schools: